About Us
Mission and Value
Leadership
Faculty
Staff
Contact Us
Research & Technology
CR1:
Infectious Immunology
CR1: Infectious Immunology
CR2 :
Multiple Neurological Disorders
CR2 : Multiple Neurological Disorders
CR3 :
Metabolic-Cancer Disorders
CR3 : Metabolic-Cancer Disorders
CT1 :
AI & Bio
CT1 : AI & Bio
CT2 :
Quantum & Bio
CT2 : Quantum & Bio
CE1 :
Nano & Bio
CE1 : Nano & Bio
CE2 :
Human Machine Interface
CE2 : Human Machine Interface
BCCI Center
BCCI Center
Y-DDC
(Yonsei-Drug Discovery Center)
Y-DDC (Yonsei-Drug Discovery Center)
Digital Health Center
Cyro-EM/ET Center
Omics Center
AI & Quantum Center
Reservation Guide
News & Media
News & Media
Events
Careers
Job Openings
Ph.D Degree Program
PostDoc program
Faculty program
게시판(퍼블)
News
Notice
Events
Faculty
모바일 메뉴 열기
About Us
Mission and Value
Leadership
Faculty
Staff
Contact Us
Research & Technology
CR1: Infectious Immunology
CR2 : Multiple Neurological Disorders
CR3 : Metabolic-Cancer Disorders
CT1 : AI & Bio
CT2 : Quantum & Bio
CE1 : Nano & Bio
CE2 : Human Machine Interface
BCCI Center
BCCI Center
Y-DDC (Yonsei-Drug Discovery Center)
Digital Health Center
Cyro-EM/ET Center
Omics Center
AI & Quantum Center
Reservation Guide
News & Media
News & Media
Events
Careers
Job Openings
Ph.D Degree Program
PostDoc program
Faculty program
게시판(퍼블)
News
목록
상세
등록
Notice
목록
Events
목록
Faculty
목록
상세
등록
모바일 메뉴 닫기
Faculty
Home
About Us
Faculty
BACK
Yong-Sun Bahn
ORCID
Google Scholar
Research Keywords
Research Interest
Education
Professional Career
Patent & Technology transfer
Prev
Next
Awards and Honors
{"firstName":"Yong-Sun","lastName":"Bahn","position":"Professor","department":"Department of Biotechnology, College of Life Science and Biotechnology, Yonsei University","homepages":["www.bahnlab.com"],"homepage":"www.bahnlab.com","orcid":"","googleScholar":"https://scholar.google.com/citations?user=pXAOKw0AAAAJ&hl=en","emails":["ysbahn@yonsei.ac.kr"],"email":"ysbahn@yonsei.ac.kr","phoneOffice":"02-2123-5558","phoneNumbers":[],"phoneLab":"","thumbAlt":"","listDescription":"","listThumbAlt":"","visibility":"public","researchKeywords":["Medical mycology","Fungal genetics and biology","Fungal pathogenesis","Antifungal development"],"researchInterest":["Characterizing the complex fungal signaling pathways and networks in a genome-wide scale","Understanding fungal pathogenicity and pathogenesis","Develop novel antifungal drug therapies"],"education":[{"period":"1997-2003","content":"The Ohio State University (Ph.D. in Molecular Virology, Immunology and Medical Genetics)"},{"period":"1995-1997","content":"Yonsei University (M.S. in Food and Biotechnology)"},{"period":"1989-1995","content":"Yonsei University (B.S. in Food and Biotechnology)"}],"career":[{"period":"2021-present","content":"Underwood Distinguished Professor, Yonsei University"},{"period":"2019-present","content":"Fellow, American Academy of Microbiology (AAM)"},{"period":"2016-present","content":"Professor, Dept. of Biotechnology, Yonsei University"},{"period":"2008-2015","content":"Assistant/Associate Professor, Dept. of Biotechnology, Yonsei University"},{"period":"2006-2008","content":"Full-time lecturer (tenure-track), Dept. of Bioinformatics, Soongsil University"},{"period":"2003-2006","content":"Postdoc fellow, Duke University Medical Center, Durham, NC"}],"patents":[{"year":"2022","content":"AmtixBio, “크립토코쿠시스 네오포만스에 의한 진균 감염 치료를 위한 당전이효소 유전자 CnKTR3의 용도 외 1건 특허 양도 계약”, 계약 총액: 3,000,000 KRW"},{"year":"2021","content":"Cellartgen (Inc), “MICROFLUIDIC DEVICE OF SIMULATING NEUROVASCULAR UNIT AND HIGHLY EFFICIENT SYSTEM FOR SIMULATING BLOOD BRAIN BARRIER COMPRISING THE SAME (뇌혈관 모사용 미세유체 디바이스 및 이를 포함하는 고효율 혈액뇌관문 모사 시스템)”, 계약 총액 : 110,000,000 KRW/ 지분율 : 9% (9,625,000 KRW)"},{"year":"2020","content":"AmtixBIO, “USE OF THE GENES ASSOCIATED WITH BLOOD-BRAIN BARRIER PASSAGE AND SURVIVAL IN BRAIN TISSUES OF MENINGOENCEPHALITIS-CAUSING FUNGI (뇌수막뇌염 유발 진균의 뇌-혈관 장벽 통과 및 뇌-내부 생존 관련 유전자의 용도)”, 계약 총액 : 55,000,000 KRW/ 지분율 : 100% (55,000,000 KRW)"},{"year":"2019","content":"AmtixBIO, “Novel aminoalkanoic acid derivatives having biphenyl group and antifungal pharmacuetical composition comprising the same (신규한 아미노알칸산에 바이페닐기를 도입한 유도체 화합물 및 이를 포함하는 항진균성 약학적 조성물)”, 계약 총액 : 66,000,000 KRW/ 지분율 : 48% (32,000,000 KRW)"},{"year":"2016","content":"AmtixBIO, “뇌수막염을 포함한 진균감염질환 치료약물”, 계약 총액 : 50,000,000 KRW/ 지분율 : 100% (50,000,000 KRW)"},{"year":"2015","content":"AmtixBIO, “Anti-fungal development technic of Cryptococcus neoformans (Crytococcus neoformans균주를 활용한 항진균제 개발 기술)”, 계약 총액 : 55,000,000 KRW/ 지분율 : 100% (55,000,000 KRW)"},{"year":"2015","content":"Intron Biotechnology(Inc), “Tacrolimus derivative”, 지분액 25,000,000 KRW"}],"awards":[{"period":"2023","content":"CJ Special Academic Award, The Korean Society for Microbiology and Biotechnology"},{"period":"2020","content":"Academic Achievement Award, The Korean Society for Microbiology and Biotechnology"},{"period":"2018","content":"Woojae Academic Award, The Korean Society for Microbiology and Biotechnology"},{"period":"2018","content":"Excellent Research Achievement Award, Yonsei University"},{"period":"2018","content":"Minister’s Commendation, Agricultural, Food and Rural Affairs Technology Awards, Korea"},{"period":"2017","content":"Medytox Academic Achievement Award, The Microbiological Society of Korea"}]}